Delivery Order SPE2DB22D1106-SPE2DB25FEYR2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,202.00 for 180 tablets of Janumet XR 50-1,000 mg, a diabetes medication combining metformin and sitagliptin. Awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, this firm fixed price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,376.56 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (60-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,151.92 firm fixed-price contract is for the delivery of JANUMET 50-1,000 milligram tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,417.63 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded delivery order, utilizing firm fixed pricing with no set-aside designation, represents pharmaceutical procurement under AmerisourceBergen's broader supply agreement with the federal government. The product will be delivered to the company's facility in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,552.65 firm fixed-price contract is for the supply of JANUMET 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,086.66 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $1,673.93. This is a non-set-aside competitive award with an ultimate completion date of July 25, 2025. The vendor will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $23,441.52 firm-fixed-price contract is for the supply of Janumet 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. The order has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYR2Delivery Order
The Defense Logistics Agency awarded a $2,408.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg, a combination medication used to treat type 2 diabetes. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the place of performance requirement from its corporate office location. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp has demonstrated consistent capability to meet DLA requirements across multiple therapeutic domains through competitive procurement processes, positioning the company as a critical vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/18/25 |